Related Experiment Videos
A quicker preparation method for autologous fibrin glue
Biological & Pharmaceutical Bulletin
|January 9, 1999
Summary
Optimizing cryoprecipitate (Cryo) preparation for fibrin glue involves specific freezing and thawing techniques. Storing plasma at -20°C and using gentle shaking during freezing and thawing maximizes coagulation factor yields.
Area of Science:
- Biochemistry
- Hematology
- Medical Technology
Background:
- Cryoprecipitate (Cryo) is utilized as fibrin glue in surgical applications.
- Current preparation methods for autologous Cryo can be time-consuming.
- Enhancing the yield of coagulation factors in Cryo is crucial for its efficacy.
Purpose of the Study:
- To develop a faster method for preparing autologous cryoprecipitate.
- To investigate the impact of different preparation conditions on coagulation factor concentrations and yields in Cryo.
- To optimize Cryo preparation for use as fibrin glue.
Main Methods:
- Human plasma from healthy volunteers was subjected to various freezing, shaking, and thawing conditions.
- Cryoprecipitate was isolated from treated plasma samples.
- Concentrations of fibrinogen, plasminogen, fibronectin, and factor XIII in Cryo were quantified.
Main Results:
- Cryoprecipitate derived from plasma stored at -20°C exhibited significantly higher concentrations and yields of plasma components compared to plasma stored at -80°C.
- Incorporating shaking at 70 cycles/min during the freezing process positively influenced coagulation factor concentrations and yields.
- A shaking thaw process in a cold water bath proved to be an efficient method for achieving adequate coagulation factor yields.
- Shaking during the defrosting phase did not significantly alter coagulation factor yields.
Conclusions:
- High-concentration cryoprecipitate can be rapidly prepared from autologous plasma within 4-5 hours.
- Optimized freezing and thawing protocols enhance the yield of essential coagulation factors.
- This streamlined preparation procedure facilitates the efficient production of cryoprecipitate for fibrin glue applications.